Immunoglobulin for Polyneuropathy

J Gordon Millichap

doi:10.15844/pedneurbriefs-4-2-1

Immunoglobulin for Polyneuropathy

Pediatric Neurology Briefs

Volume 4 (1990): Issue 2

By: J Gordon Millichap

Open Access

|Feb 1990

Abstract

The value of high-dose intravenous immunoglobulin in the treatment of chronic inflammatory demyelinating polyneuropathy was studied in a double-blind, placebo controlled, crossover investigation at the Department of Neurology, University Hospital Rotterdam-Dijkzigt, the Department of Immunohematology and Bloodbank, University Hospital Leiden, and the Central Laboratory of the Netherlands, Red Cross Blood Transfusion Service, Amsterdam, The Netherlands.

References

van Doorn PA Brand A Strengers PF Meulstee J Vermeulen M High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: A double-blind, placebo-controlled, crossover study Neurology 1990 Feb 40 2 209 212 10.1212/WNL.40.2.209 2405291
Open DOI Search in Google Scholar Back to article
Cook JD Delgrado MR Soutter-Glass D Neurology 1987 37 suppl 1 253
Search in Google Scholar Back to article
Cook D Dalakas M Galdi A Biondi D Porter H High-dose intravenous immunoglobulin in the treatment of demyelinating neuropathy associated with monoclonal gammopathy Neurology 1990 Feb 40 2 212 214 10.1212/WNL.40.2.212 2153942
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-4-2-1 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 9 - 10

Published on: Feb 1, 1990

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Immunoglobulin,

Guillain-Barre Syndrome,

Monoclonal Gammopathy

© 1990 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 4 (1990): Issue 2